首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2200篇
  免费   173篇
  国内免费   2篇
耳鼻咽喉   53篇
儿科学   107篇
妇产科学   19篇
基础医学   272篇
口腔科学   94篇
临床医学   168篇
内科学   427篇
皮肤病学   24篇
神经病学   109篇
特种医学   18篇
外科学   360篇
综合类   64篇
一般理论   1篇
预防医学   218篇
眼科学   137篇
药学   161篇
中国医学   8篇
肿瘤学   135篇
  2023年   13篇
  2022年   42篇
  2021年   103篇
  2020年   42篇
  2019年   51篇
  2018年   65篇
  2017年   56篇
  2016年   74篇
  2015年   75篇
  2014年   91篇
  2013年   101篇
  2012年   167篇
  2011年   157篇
  2010年   94篇
  2009年   91篇
  2008年   137篇
  2007年   121篇
  2006年   125篇
  2005年   94篇
  2004年   85篇
  2003年   68篇
  2002年   69篇
  2001年   52篇
  2000年   35篇
  1999年   44篇
  1998年   23篇
  1997年   13篇
  1996年   16篇
  1995年   15篇
  1994年   11篇
  1992年   13篇
  1991年   17篇
  1990年   29篇
  1989年   19篇
  1988年   13篇
  1987年   10篇
  1986年   17篇
  1985年   12篇
  1983年   9篇
  1981年   5篇
  1980年   4篇
  1979年   13篇
  1978年   8篇
  1977年   4篇
  1976年   8篇
  1975年   5篇
  1973年   7篇
  1972年   6篇
  1966年   4篇
  1961年   8篇
排序方式: 共有2375条查询结果,搜索用时 234 毫秒
1.
2.
Norethisterone enanthate (NET-En), an established intramuscular long-acting contraceptive agent, has previously been shown to be effective in inhibiting fertility in two rodent species even 4 days after oral ingestion. Pharmacokinetics of NET and NET-En were studied after oral and intramuscular doses in two animal species and a few women. The results suggest that the NET-En was absorbed within a day in all the species after oral dose. The estimates of relative bioavailability ranged from 13 to 51% in rabbits, monkeys, and women. The elimination half-life was 5–10 days. The presence of the active component, NET, in the circulation over the experimental period of 15 days suggests that NET-En could be useful as a long-acting oral pill. The suppression of progesterone levels during the luteal phase of menstrual cycle in women also supports this finding.  相似文献   
3.
4.
The treatment of keloid and hypertrophic scars remains difficult. Enzymatic digestion of keloid scars has been previously proposed as an effective treatment strategy for reducing the volume of keloid scars. To test this, we administered intra-lesional injections of pure collagenase (between 600 and 4500 units for each scar) into the keloid and hypertrophic scars of seven human volunteers (five keloid and two hypertrophic scars). Five patients (three keloid and two hypertrophic) received more than one injection of collagenase. The treatment resulted in a temporary reduction in scar volume for three of the patients with keloid scars. However, scar volumes for these three patients returned to the same (or greater) levels after 6 months of follow-up. Treatment with collagenase produced no change in scar volume for the two patients with hypertrophic scar. Side effects were numerous and severe including; pain, swelling, blistering, ulceration and ecchymosis at the site of injection. One patient required admission to hospital for 48 h after the first injection. Maximum length of follow-up was 6 months. None of the seven patients completed the study and returned for final follow-up at 2 years. This pilot study suggests that treatment of keloid and hypertrophic scars with intra-lesional injections of collagenase is ineffective.  相似文献   
5.
Intra-articular fractures of the proximal tibia present a wide spectrum of injury patterns with associated soft tissue injury. The last two decades have seen the techniques of management evolve from extensive open reduction and rigid internal fixation to arthroscopy-assisted minimal invasive surgery (MIS) and biologically benign internal fixation. The ultimate aim is to prevent the occurrence of late degenerative arthritis. This could be achieved in selected patients using minimal invasive surgery, which offers the advantages of better visualisation and management of intra-articular soft tissue injuries, confirmation of fracture reduction viewed from the joint surface, faster rehabilitation and fewer wound complications.  相似文献   
6.
7.
Hypersensitivity reactions occurring during barium studies of the gastrointestinal tract are rare. A case is presented with radiographically demonstrated angioedema in the stomach and small bowel accompanied by allergic rhinitis, which was apparently an allergic response to the barium sulfate suspension. The reaction was documented twice during separate challenges to the barium suspension performed several months apart.  相似文献   
8.
Backscatter imaging is useful for inspecting structures that are accessible only from one side. However, indications provided by scattered radiation are typically weak, convoluted and difficult to interpret. This paper explores the use of the coded aperture technique to detect flaws using gamma-ray backscatter imaging. The viability of this approach is demonstrated with indications obtained from Monte Carlo simulations of radiation scattering measurements. The results show that, with a 2 mm wide beam of 137Cs photons, flaws as small as 1.5 mm in width can be detected using this technique. Indications of changes in flaw size, location, multiplicity and density were also observable. In addition, it is possible to quantify, from the decoded indications, the flaw location and its size.  相似文献   
9.
10.
Studies reported here indicate that an anti-Ia immunotoxin can eliminate the allostimulatory subpopulation of cells present within the islets of Langerhans without damaging the hormone-secreting cells. Such studies made use of an in vitro correlate of transplantation rejection, the mixed lymphocyte islet cell (MLIC) reaction. Using the MLIC, it was demonstrated that an anti-Ia immunotoxin removed cells capable of stimulating the MLIC in a dose-dependent fashion without altering the hormone-secreting functions of the remaining cells when challenged with glucose and theophylline. These studies suggest the feasibility of using such anti-Ia immunotoxins in islet allograft transplantation models to circumvent problems inherent in complement-mediated cytotoxicity, a previously documented effective form of inducing islet allotransplantation tolerance.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号